Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.540
-0.025 (-4.42%)
At close: Nov 20, 2024, 4:00 PM
0.530
-0.010 (-1.85%)
After-hours: Nov 20, 2024, 7:57 PM EST
MTNB Market Cap
MTNB has a market cap or net worth of $2.71 million as of November 21, 2024. Its market cap has decreased by -95.05% in one year.
Market Cap
2.71M
Enterprise Value
-5.02M
1-Year Change
-95.05%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $2.71M, a decrease of -98.79%. That is a compound annual growth rate of -43.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.90M | -93.83% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
| Mar 2, 2017 | 223.50M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aditxt | 3.15M |
| Palisade Bio | 3.12M |
| Enveric Biosciences | 3.04M |
| iSpecimen | 3.02M |
| Aptorum Group | 2.94M |
| Theriva Biologics | 2.91M |
| Lipella Pharmaceuticals | 2.90M |
| Bio-Path Holdings | 2.89M |